Journey Medical Corp (DERM)

EBITDA Growth

192.12%

Quarterly · Period ending:

DERM logo

DERM EBITDA Growth

Year-over-year change vs the same period a year earlier

Latest reported192.12%
DERM Quarterly EBITDA YoY % (-346.49% → 192.12%)
High-resolution chart · PNG

DERM ebitda growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Journey Medical Corp EBITDA Growth — Quarterly
Period endingEBITDA Growth
192.1191%
90.9828%
-77.3419%
63.2704%
12.5574%
76.8602%
395.7576%
-104.4196%
69.9402%
-7.8976%
86.8211%
312.3229%
-6.8536%
-5,551.2987%
-40.3587%
-1,575.9582%
48.3179%
-87.0588%
-255.9051%
-7.1197%
-715.2763%
-49.8314%
101.1643%
113.5185%
103.8872%
15.3764%
14.3702%
-14.5719%
-30.2681%
64.2619%
55.1353%
-78.6589%
-614.8068%
-3,419.1377%
-39.0527%
-2,692.2609%
75.9042%
131.9884%
-53.1396%
107.9679%
-346.4861%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.